158 related articles for article (PubMed ID: 399191)
1. Drug metabolism.
Tucker GT
Br J Anaesth; 1979 Jul; 51(7):603-18. PubMed ID: 399191
[No Abstract] [Full Text] [Related]
2. Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Held at Utrecht, The Netherlands, 6-8 September 1994.
Skett P; Tyson C; Guillouzo A; Maier P
Biochem Pharmacol; 1995 Jul; 50(2):280-5. PubMed ID: 7632175
[No Abstract] [Full Text] [Related]
3. The metabolism of drugs by isolated hepatocytes.
Fry JR
Q Rev Drug Metab Drug Interact; 1982; 4(2-3):99-122. PubMed ID: 6765366
[TBL] [Abstract][Full Text] [Related]
4. [Drug-induced hepatopathies].
Kirchmayer S
Pol Arch Med Wewn; 1974 May; 51(5):519-30. PubMed ID: 4832828
[No Abstract] [Full Text] [Related]
5. Drug-induced hepatotoxicity.
Lee WM
N Engl J Med; 1995 Oct; 333(17):1118-27. PubMed ID: 7565951
[No Abstract] [Full Text] [Related]
6. Drugs and the liver: a review of metabolism and adverse reactions.
Schaffner F; Raisfeld IH
Adv Intern Med; 1969; 15():221-51. PubMed ID: 4908619
[No Abstract] [Full Text] [Related]
7. Editorial: Role of Drug Metabolism and its Mediated DDI in Drug Efficacy and Safety Part 2.
Liu C; He X
Curr Drug Metab; 2015; 16(10):848-9. PubMed ID: 26652253
[No Abstract] [Full Text] [Related]
8. Nutrition, age and drug metabolism.
Dickerson JW; Walker R
Proc Nutr Soc; 1974 Dec; 33(3):191-6. PubMed ID: 4459962
[No Abstract] [Full Text] [Related]
9. Clinical pharmacology. Drugs in children.
Rylance G
Br Med J (Clin Res Ed); 1981 Jan; 282(6257):50-1. PubMed ID: 6778567
[No Abstract] [Full Text] [Related]
10. Influence of disease on drug toxicity.
Turner P
Arch Toxicol Suppl; 1984; 7():33-8. PubMed ID: 6596000
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of drug metabolism--introduction.
Azarnoff DL
Chem Biol Interact; 1971 Aug; 3(4):241-2. PubMed ID: 5132989
[No Abstract] [Full Text] [Related]
12. Strategic proposals to avoid toxic drug interactions during new drug development: molecular toxicology proposals.
Kamataki T; Yokoi T; Yamayoshi Y; Nakamura K; Kushida H; Fujita K; Mitsuhashi H; Ueno T
J Toxicol Sci; 1996 Dec; 21(5):305-8. PubMed ID: 9035042
[No Abstract] [Full Text] [Related]
13. Drugs and the liver.
Reidenberg MM; Breckenridge A
Clin Pharmacol Ther; 1998 Oct; 64(4):353-4. PubMed ID: 9797790
[No Abstract] [Full Text] [Related]
14. Drug-induced liver disease.
Sumner HW; Holtzman JL; McClain CJ
Geriatrics; 1981 Oct; 36(10):83-96. PubMed ID: 7274672
[No Abstract] [Full Text] [Related]
15. Drugs in liver disease.
Branch RA
Clin Pharmacol Ther; 1998 Oct; 64(4):462-5. PubMed ID: 9797803
[No Abstract] [Full Text] [Related]
16. Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions.
Abernethy DR; Flockhart DA
Circulation; 2000 Apr; 101(14):1749-53. PubMed ID: 10758060
[No Abstract] [Full Text] [Related]
17. Clinical pharmacology. Adverse drug interactions.
Aronson JK; Grahame-Smith DG
Br Med J (Clin Res Ed); 1981 Jan; 282(6260):288-91. PubMed ID: 6779990
[No Abstract] [Full Text] [Related]
18. Drug metabolism in extrahepatic diseases.
Farrell GC
Pharmacol Ther; 1987; 35(3):375-404. PubMed ID: 3324119
[No Abstract] [Full Text] [Related]
19. [Hepatopathies and drugs].
González Macias J; De Castro del Pozo S
Rev Esp Enferm Apar Dig; 1974; 44(2):175-86. PubMed ID: 4418081
[No Abstract] [Full Text] [Related]
20. [Various frequent drug complications. Role of clinical biology in the detection and prevention of undesirable effects of medications].
Delwaide PA
Rev Med Liege; 1981 May; 36(1):441-52. PubMed ID: 7256034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
